After a melanoma diagnosis, mRNA cancer vaccine delivered a patient hope — and a path forward

Summary

A patient case study describes the experience of being treated with an mRNA cancer vaccine for melanoma developed by Merck and Moderna. The article highlights the vaccine's potential as a treatment option for melanoma patients.